AstraZeneca Pharma India Limited

Price Chart

Risk-Adjusted Performance

AstraZeneca Pharma India Limited (ASTRAZEN) Price Performance

AstraZeneca Pharma India Limited (ASTRAZEN) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR8276.00, down 0.54% from the previous close.

Over the past year, ASTRAZEN has traded between a low of INR7810.80 and a high of INR10473.70. The stock has lost 1.0% over this period. It is currently 21.0% below its 52-week high.

AstraZeneca Pharma India Limited has a market capitalization of $215.23B, with a price-to-earnings ratio of 107.53.

About AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.